Uso de apósitos con TLC-NOSF en el manejo de la úlcera de pie diabético, basado en la revisión de la evidencia y la práctica clínica.

Management of diabetic foot ulcers with a TLC-NOSF dressing, based on evidence and clinical practice The incidence of diabetic foot ulcers (DFU) has increased in the past decade, both in Chile and worldwide, as a result of the progressive growth in diabetes prevalence. Because DFU are associated with a high risk of infection and amputation, it is crucial to choose effective and evidence-based treatments. A dressing combining technology lipidocolloid with nano-oligo saccharide factor (TLC-NOSF) has demonstrated its effectiveness in managing DFU. This article reviews the evidence around TLC-NOSF and its implementation in clinical practice.

CONFLICTO DE INTERÉS: FSS recibió pagos personales de Laboratorios UrgoMedical por ponencias y actividades. RCG es empleada de Laboratorios UrgoMedical. APP declara no tener conflicto de interés.

Estudio de diabetes mellitus y pie diabético en la internación: datos de Argentina / Diabetes mellitus and diabetic foot in patients study: data from Argentina

Introducción: el pie diabético es una complicación que se presenta del 15 al 25% de los pacientes con diabetes mellitus (DM) a lo largo de su vida. Una vez que aparece, demanda un abordaje multidisciplinario y a menudo requiere internación. Estas internaciones suelen ser prolongadas y costosas dado que para su atención se necesitan complejos procedimientos de diagnóstico y tratamiento. En este contexto, el conocimiento de los datos acerca de la internación de pacientes con pie diabético es importante al momento de tomar decisiones de salud pública e implementar acciones para la prevención, derivación temprana, referencia y contrarreferencia de pacientes. Objetivos: el objetivo de este estudio fue determinar la prevalencia de DM y la tasa de pie diabético (PD) en pacientes internados. Materiales y métodos: se estudiaron 6.776 pacientes internados en 104 instituciones argentinas. El estudio se realizó durante un día elegido por cada institución dentro de un lapso de dos meses (septiembre y octubre de 2017). Resultados: la prevalencia de DM fue de 17,86% y la tasa de PD 14,11%. La tasa de pie diabético con lesiones Wagner 1 o mayor fue de 4,47%. El pie diabético fue el motivo de internación en el 3,16% del total de internados y al 17,85% de los diabéticos internados. Conclusiones: en nuestro conocimiento, este trabajo es el primero realizado en Argentina que abarca ese tamaño muestral y sienta precedente para nuevos trabajos de investigación en el tema

Introduction: diabetic foot is a chronic complication that occurs in 15% to 25% of diabetic patients. Once it appears, a multidisciplinary team shoud be necessary to care for that patients. Patients suffering from diabetic foot often requires treatment as inpatients. In this context, knowlege about information related to the hospitalization of diabetic foot is very important in making decisions about public health, related to prevention and treatment. Objectives: the purpose of this study was to determinate the prevalence of diabetes and the rate of diabetic foot among patients. Materials and methods: a total of 6,776 patients were studied in 104 Argentine institutions. The study was conducted during a day chosen by each institution within a period of two months (September and October 2017). Results: the prevalence of diabetes mellitus was 17.86%, while the rate of diabetic foot was 14.11%. The rate of diabetic foot classified as Wagner >=1 was 4.47%. Diabetic foot was the reason for admission in 3.16% of patients and 17.85% of diabetic patients. Conclusions: in our knowledge, this is the largest study in Argentina and lays the foundation for further investigation in this topic

[Diabetic foot among hospitalized patients in Latin America]. / Pie diabético en pacientes internados en hospitales de Latinoamérica.

The diabetic foot is a complex condition. Along its course, it may require primary health care at the beginning, tertiary health care when more severe complications arise, and hospitalization when specialized management involving complex diagnostic and therapeutic procedures becomes peremptory. Determining frequencies of diabetic foot in hospitalized patients provides baseline data on the status of this condition aiming to an effective decision making process at the public health level. This transversal study consisted in analyzing data of 11 357 inpatients from 135 health centers in 9 Latin American countries in order to assess the prevalence of diabetes mellitus, the frequency of diabetic foot and related parameters in hospitalized patients in the region. The prevalence of diabetes mellitus was 18.6% (IC 95%; 14.1-15.4). The rate of diabetic foot was 14.8% (IC 95%; 14.1-15.4) and that of diabetic foot classified as Wagner = 1 was 5.8% (IC 95%; 4.8-5.6). Diabetic foot was the reason for admission for 3.7% of all inpatients and for 20% of those who were diabetic. In our knowledge, this study is the largest in Latin America, and lays the foundation for further advances in the knowledge of the burden of diabetic foot.